Respiratory muscle dysfunction in long-COVID patients.
COVID-19
Long COVID
P0.1
P0.1/PImax
PImax
SARS-CoV-2
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
07
12
2021
accepted:
23
04
2022
pubmed:
16
5
2022
medline:
4
10
2022
entrez:
15
5
2022
Statut:
ppublish
Résumé
Symptoms often persistent for more than 4 weeks after COVID-19-now commonly referred to as 'Long COVID'. Independent of initial disease severity or pathological pulmonary functions tests, fatigue, exertional intolerance and dyspnea are among the most common COVID-19 sequelae. We hypothesized that respiratory muscle dysfunction might be prevalent in persistently symptomatic patients after COVID-19 with self-reported exercise intolerance. In a small cross-sectional pilot study (n = 67) of mild-to-moderate (nonhospitalized) and moderate-to-critical convalescent (formerly hospitalized) patients presenting to our outpatient clinic approx. 5 months after acute infection, we measured neuroventilatory activity P Pathological P Our findings point towards respiratory muscle dysfunction as a novel aspect of COVID-19 sequelae. Thus, we strongly advocate for systematic respiratory muscle testing during the diagnostic workup of persistently symptomatic, convalescent COVID-19 patients.
Identifiants
pubmed: 35570238
doi: 10.1007/s15010-022-01840-9
pii: 10.1007/s15010-022-01840-9
pmc: PMC9108020
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1391-1397Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022. The Author(s).
Références
Wichmann D, Sperhake JP, Lutgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schroder AS, et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med. 2020;173:268–77.
doi: 10.7326/M20-2003
Puelles VG, Lutgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, Liu S, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383:590–2.
doi: 10.1056/NEJMc2011400
Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626–31.
doi: 10.1038/s41591-021-01292-y
Hennigs JK, Oqueka T, Harbaum L, Klose H. Organ-specific sequelae of COVID-19 in adults. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022;65:462–70.
doi: 10.1007/s00103-022-03513-2
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220–32.
doi: 10.1016/S0140-6736(20)32656-8
Lam GY, Befus AD, Damant RW, Ferrara G, Fuhr DP, Stickland MK, Varughese RA, Wong EY, Smith MP. Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype? Respir Res. 2021;22:222.
doi: 10.1186/s12931-021-01814-9
Laveneziana P, Albuquerque A, Aliverti A, Babb T, Barreiro E, Dres M, Dube BP, Fauroux B, Gea J, Guenette JA, et al. ERS statement on respiratory muscle testing at rest and during exercise. Eur Respir J. 2019. https://doi.org/10.1183/13993003.01214-2018 .
doi: 10.1183/13993003.01214-2018
pubmed: 31857385
Kabitz HJ, Windisch W. Respiratory muscle testing: state of the art. Pneumologie. 2007;61:582–7.
doi: 10.1055/s-2007-980080
Klok FA, Boon G, Barco S, Endres M, Geelhoed JJM, Knauss S, Rezek SA, Spruit MA, Vehreschild J, Siegerink B. The post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020. https://doi.org/10.1183/13993003.01494-2020 .
doi: 10.1183/13993003.01494-2020
pubmed: 32398306
pmcid: 7236834
Shi Z, de Vries HJ, Vlaar APJ, van der Hoeven J, Boon RA, Heunks LMA, Ottenheijm CAC. Dutch C-DI: diaphragm pathology in critically ill patients with COVID-19 and postmortem findings from 3 medical centers. JAMA Intern Med. 2020. https://doi.org/10.1001/jamainternmed.2020.6278 .
doi: 10.1001/jamainternmed.2020.6278
pubmed: 32744593
pmcid: 7670391
Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435–52.
doi: 10.1164/rccm.201111-2042ST